Global Postmenopausal Osteoporosis Market Size study, by Treatment (Vitamin D, Bisphosphonates, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Reg

Global Postmenopausal Osteoporosis Market Size study, by Treatment (Vitamin D, Bisphosphonates, Hormone Replacement Therapy, Parathyroid Hormone Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Forecasts 2022-2028

Global Postmenopausal Osteoporosis Market is valued at approximately USD XXX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Osteoporosis is a chronic bone condition that primarily affects postmenopausal women and has a propensity to get worse with ageing. The effects include a loss of bone density and a sharp decline in the integrity of the interior spongy structure until the bone breaks because of being unable to tolerate external pressures and strains. The market growth is driven by key factors such as investment by market players and thereby strong pipeline and increase in geriatric population. For instance, according to WHO, in the period between 2015 and 2050, the percentage of the global geriatric population—those older than 60—is projected to double, rising from 12 to 22 percent. These results demonstrated a steady rise in the number of elderly people who have postmenopausal osteoporosis over the research period (aged between 50 years to 60 years). Furthermore, some of the risk factors for osteoporosis in women after menopause include ageing, smoking, alcohol usage, and the use of drugs to treat various disorders, such as gonadotropins, excessive thyroid hormone use, and cytotoxic agents. More than 200 million women are thought to have osteoporosis, and 1 in 3 women over 50 are predicted to have an osteoporosis fracture, according to research from the International Menopause Society (IMS) released in 2021. Also, with the new product launches and increase in Clinical trials for better diagnostic solutions likely to increase the market growth during the forecast period. However, low awareness of Postmenopausal Osteoporosis impedes the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Postmenopausal Osteoporosis Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the global market share owing to developed healthcare infrastructure and high diagnosis and thereby treatment rate. However, Asia Pacific is expected to be the fastest growing region due to large number of generic manufacturer and rise in government initiatives and specialist communities.

Major market players included in this report are:
Amgen Inc.
Novartis International AG
Merck & Co., Inc
Proctor & Gamble Co.
Eli Lilly and CO.
Enteris BioPharma
Pfizer Inc
Oncobiologics, Inc.
Clonz Biotech
Ligand Pharmaceuticals Incorporated
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment:
Vitamin D
Bisphosphonates
Hormone Replacement Therapy
Parathyroid Hormone Therapy
Others

By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Postmenopausal Osteoporosis Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Companies Mentioned

Amgen Inc.
Novartis International AG
Merck & Co., Inc
Proctor & Gamble Co.
Eli Lilly and CO.
Enteris BioPharma
Pfizer Inc
Oncobiologics, Inc.
Clonz Biotech
Ligand Pharmaceuticals Incorporated

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.